They find the damage (homing)
Introduced cells respond to signals from damaged tissue and migrate precisely to the problem area.
Cellular medicine · regeneration
MSC therapy — a regenerative approach to tissue and joints
Mesenchymal stem cells (MSCs) take part in the body's natural tissue renewal. They are considered when a joint, ligament or tissue is slow to recover and pain relief doesn't address the cause. In Boao Lecheng this is run to an individual plan, after consultation and diagnostics. The physician prescribes the programme.
- Outpatient
- Intravenous or targeted to the area
- Your own or cord-derived cells
- Course — per the physician's plan
About the method
What is MSC therapy
Mesenchymal stem cells are the body's repair crew. They can differentiate into different cell types and respond to signals from damaged tissue. For therapy they are obtained by protocol — from blood, adipose tissue, bone marrow or a cord source — then purified and activated in the lab.
The mechanism is subtler than simply “replacing cells.” MSCs act more like a conductor: they release signalling molecules that switch on the body's own repair processes, help calm local inflammation and improve tissue nourishment.
They can be given in different ways: intravenously for a systemic effect, or targeted into a joint, ligament or affected area. The physician chooses the route for your goal.
The science is solid: the role of stem cells in tissue self-repair was discussed as early as Science (1999) and Nature (2007). This is not a guarantee of result — a physician decides whether the method is needed.
How it works
The principle
They start repair (paracrine effect)
The main action isn't “replacing” cells but signalling: MSCs release growth factors that switch on the body's own tissue-renewal processes. In short — they work as a conductor of repair.
They balance inflammation
They help calm an excessive local inflammatory response — as assessed by a physician.
They improve tissue nourishment
They support blood supply and trophism (nourishment) in the recovery zone.
Scientific basis
Origin and scientific basis
Facts about the method's origin, standards and quality control — what trust is built on. This is not a promise of a result: a physician decides whether it's right for you.
- Studied for decades
Mesenchymal stem cells (MSCs) have been described and actively studied since the late 1990s; their regenerative potential is a subject of global science.
- GMP-standard preparation
Isolation, culture and cell control follow GMP protocols, with multi-stage quality checks.
- Used by indication
In the cluster the field is considered on strict indications — for regenerative and recovery goals, by the physician's decision.
The team
Specialist physicians for this area
This area in the cluster is led by specialist physicians with years of experience and academic credentials. They prescribe and deliver the treatment — MedBridge coordinates your route.
Luo ZhihuaInternal medicine · cellular technologiesA graduate of the University of Science and Technology of China (USTC). Internal medicine, 10+ years in practice; experience with stem cells, NK and CIK. Named “Best Doctor” of the Boao Lecheng zone (2019).
Wang JunchengRegenerative medicine · vascular surgeryDeputy chief physician; a graduate of Zhejiang University, a “highly qualified specialist” of Hainan (2019). Experience with LaViv, PRP, stem and immune cells for joint, nervous-system and anti-age recovery.
Who it's for
This may be relevant to you
Most people who consider this method recognise themselves in situations like these. It's not a prompt for self-treatment — whether it fits your case is decided by a physician after consultation and diagnostics.
- Active and not slowing down
Sport, training, an active life — and a joint or your back increasingly limits what you're used to allowing yourself.
- Tired of the painkiller loop
You want to address the cause of pain, not mute it with pills for years.
- Before deciding on surgery
You want to consider a regenerative route before agreeing to surgery — as assessed by a physician.
- After injuries and overload
Old injuries, tendinopathies and slow tissue healing get in the way of living fully.
- Thinking years ahead
You want to support joints and tissue early, before a small problem becomes a large one.
Why patients consider it
Why patients consider this method
These are reasons for interest in the method, not a promise of outcome: the physician sets the final decision and realistic expectations.
- Working with repair itself
The approach aims to support the body's own processes of tissue repair, nourishment and reduced local inflammation — as assessed by a physician.
- Precise delivery
Given systemically and/or targeted into a joint, ligament or area — as the physician decides for your goal.
- World-class standards
A GMP-grade preparation with control of sterility, viability and cell uniformity — in the regulated Boao Lecheng zone.
- Control and privacy
A personal coordinator and interpreter; outpatient, confidential, 24/7 support.
Indications
When it may be considered
May be considered by a physician for a range of conditions. A specialist determines suitability and protocol after diagnostics.
- Joints and spine: osteoarthritis, osteochondrosis, pain in knees, shoulders and back
- Sports injuries and overload
- Ligaments and tendons: chronic inflammation, tendinopathies
- Vessels and microcirculation: diabetic and ischaemic disturbances
- Skin and soft tissue: reduced elasticity, slow healing
- Neurological support — by indication
Safety
Standards and quality control
The approach is built around patient safety and verifiable quality.
- GMP-grade preparation: control of sterility, mycoplasma, endotoxins
- Checks of viability, purity and cell uniformity
- Low immunogenicity — reduces rejection risk
- Certified clinics of the Boao Lecheng cluster
Process
How it goes
- 1Diagnostics
Tests and, if needed, ultrasound or MRI.
- 2Material collection
Blood, adipose tissue or bone marrow under sterile conditions.
- 3Isolation and activation
By a standardised protocol (GMP / ISO).
- 4Culture
10–14 days to the target cell dose.
- 5Administration
Intravenously and/or locally (joint, ligament, tissue).
- 6Follow-up
Check-up in 2–4 weeks.
A course is usually 1–2 procedures, 2–4 weeks apart, outpatient. The work is done with multi-stage laboratory control. The physician assesses dynamics; the result is individual and not guaranteed.
Outcomes
What to expect, and how progress is assessed
- A gradual effect
This isn't a “result by morning”: support for the body's own repair unfolds over weeks and months.
- Dynamics measured objectively
By tests, ultrasound or MRI if needed, functional tests and follow-up visits — at 2–4 weeks and beyond.
- What it targets
Support for tissue regeneration, balance of local inflammation and better nourishment — not tissue replacement or “as-needed” pain relief.
- Honest expectations
The method supports the body's resources but does not guarantee a specific result; the physician discusses realistic expectations at consultation.
Safety
Risks, tolerability and contraindications
Openness about safety is part of a responsible approach.
- Low immunogenicity
These are immature “all-purpose” cells (multipotent) the immune system barely recognises, so the risk of rejection is minimal.
- GMP quality control
Every cell batch is tested for bacteria, fungi, mycoplasma, endotoxins, viability, purity and uniformity.
- Tolerability
By accumulated clinical experience, the most common reaction is a brief temperature rise on the procedure day, usually self-resolving. Individual tolerability is assessed by the physician.
- When it isn't performed
Contraindications usually considered include active infection, uncontrolled oncological processes, pregnancy and others. The physician decides after diagnostics.
Cost
Indicative cost
From approx. ¥5,800 (≈ $800), depending on the programme and target area
The exact cost is determined only after diagnostics — the programme is tailored individually, by indication. Payment is made directly to the cluster's clinic, by official invoice. All prices →
Diagnostics — the required first step
Every programme begins with a consultation and an accurate diagnosis (check-up). Treatment does not start without assessing indications and contraindications.
Questions
FAQ — MSC therapy
Yes. Every programme begins with a consultation and diagnostics (check-up). No therapy starts without an accurate diagnosis and assessment of contraindications — that is the basis of safety.
By protocol — from the patient's blood, adipose tissue or bone marrow; cord-derived mesenchymal cells are also used. Registered products are possible by the physician's decision.
It depends on the goal: intravenously and/or locally into a joint, ligament or tissue. The physician determines the route.
The active part of the visit is usually a few days: consultation, diagnostics, material collection and administration. Part of preparation and follow-up can be remote; exact timing depends on the programme and is agreed in advance.
Most often a brief temperature rise on the procedure day, usually self-resolving. Serious reactions with validated cells are rare; tolerability and contraindications are assessed by the physician.
Be sure to mention this at consultation: the physician takes comorbidities and medication into account when assessing indications and contraindications.
The area, volume and composition of the programme — the number and type of administrations. See the Pricing page for a guide; the exact estimate is formed after diagnostics and paid directly to the clinic.
Discuss the programme with a coordinator
Tell us your situation and medical goal — we'll advise which documents help prepare a preliminary review and what the next steps could be.